| 标题 |
Ameli-01: A Phase I Trial of UCART123v1.2, an Anti-CD123 Allogeneic CAR-T Cell Product, in Adult Patients with Relapsed or Refractory (R/R) CD123+ Acute Myeloid Leukemia (AML) |
| 网址 | |
| DOI |
10.1182/blood-2022-169928
doi
|
| 其它 |
期刊:Blood 作者:David A. Sallman; Daniel J. DeAngelo; Naveen Pemmaraju; Shira Dinner; Saar Gill; et al 出版日期:2022-11-15 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)